Catheter Precision (VTAK) Non-Current Deffered Revenue (2017 - 2021)

Catheter Precision (VTAK) has 5 years of Non-Current Deffered Revenue data on file, last reported at $566000.0 in Q2 2021.

• On a quarterly basis, Non-Current Deffered Revenue fell 33.1% year-over-year to $566000.0 in Q2 2021; TTM through Jun 2021 was $566000.0, a 33.1% decrease from a year earlier, with the FY2020 full-year figure at $686000.0, down 44.32% from the prior year.
• Non-Current Deffered Revenue for Q2 2021 stood at $566000.0, down from $617000.0 in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for VTAK reached as high as $1.2 million in Q4 2019 and fell as low as $566000.0 in Q2 2021.
• Historically, Non-Current Deffered Revenue has averaged $853153.8 across 5 years, with a median of $775000.0 in 2017.
• Across the five-year window, Non-Current Deffered Revenue soared 60.63% in 2019 and sank 44.32% in 2020, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $775000.0 in 2017, then dropped by 1.03% to $767000.0 in 2018, then surged by 60.63% to $1.2 million in 2019, then sank by 44.32% to $686000.0 in 2020, then slipped by 17.49% to $566000.0 in 2021.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $566000.0 in Q2 2021, $617000.0 in Q1 2021, and $686000.0 in Q4 2020.